New MRI technology by IMRIS gets approval from the United States Food and Drug Administration

IMRIS, a leading company specializing in MRI systems for operating suites, has announced the launch of its latest product - the InVision 3T Recharge MRI system. This system is designed specifically for neurosurgical imaging during procedures in an operating suite.

The InVision 3T Recharge MRI system is a ceiling-mounted diagnostic and intraoperative MRI system that incorporates Siemens' latest Skyra Fit Biomatrix technology. This technology extends the life of the initial investment, ensuring that the system remains state-of-the-art for years to come.

The system is intended for use during neurosurgery for imaging purposes and is customized for neurosurgical imaging procedures. It is tailored to provide clear and detailed images, aiding surgeons in making critical decisions during operations.

The InVision 3T Recharge MRI system is a significant upgrade for IMRIS Operating Suites currently using Magnetom Verio scanners from Siemens Healthineers. It allows these suites to upgrade to the company's Magnetom Skyra Fit scanners, offering improved imaging capabilities.

The approval of the IMRIS InVision 3T Recharge MRI system by the US Food and Drug Administration (FDA) marks a milestone in the company's journey. The system is expected to provide a path for upgrading MRI technology at IMRIS Operating Suites, enhancing the value of MRI at the clinical centers where it is installed.

IMRIS's intraoperative MRI systems are not just designed for neurosurgical imaging; they are customized for neurosurgical imaging during operations. This customization ensures that the system meets the specific needs of neurosurgeons, providing them with the tools they need to perform complex procedures with precision.

In summary, the InVision 3T Recharge MRI system is a game-changer in the field of neurosurgery. Its customization, advanced technology, and FDA approval make it an invaluable tool for clinical centers specializing in neurosurgery. As IMRIS continues to innovate, we can expect to see more groundbreaking developments in the field of intraoperative MRI systems.